Overview

• The artificial lymph node (aLN) uses hyaluronic acid and immune-stimulating molecules to train T cells.
• In mouse models, the aLN significantly expanded cancer-fighting T cells and improved survival rates.
• The aLN can potentially simplify cancer treatment by reducing complex cell extraction and manipulation steps.
• Researchers observed tumor shrinkage and extended survival in mice treated with the aLN and a checkpoint inhibitor.
• Further studies are needed to test the aLN's safety and efficacy in humans.